These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20109754)

  • 1. Persistent rotavirus vaccine shedding in a new case of severe combined immunodeficiency: A reason to screen.
    Uygungil B; Bleesing JJ; Risma KA; McNeal MM; Rothenberg ME
    J Allergy Clin Immunol; 2010 Jan; 125(1):270-1. PubMed ID: 20109754
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of mutations in antigenic regions of rotavirus viral proteins 4 and 7 in a child with chronic shedding of rotavirus vaccine-type strain.
    Top KA; Esquilin JM; Yen C; Esona MD; Gentsch JR; Bhatia M; Larussa P
    Pediatr Infect Dis J; 2011 Jul; 30(7):630. PubMed ID: 21673551
    [No Abstract]   [Full Text] [Related]  

  • 3. Rotavirus vaccine--a powerful tool to combat deaths from diarrhea.
    Santosham M
    N Engl J Med; 2010 Jan; 362(4):358-60. PubMed ID: 20107222
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS).
    Bakare N; Menschik D; Tiernan R; Hua W; Martin D
    Vaccine; 2010 Sep; 28(40):6609-12. PubMed ID: 20674876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine.
    Cowley D; Boniface K; Bogdanovic-Sakran N; Kirkwood CD; Bines JE
    Hum Vaccin Immunother; 2017 Aug; 13(8):1908-1915. PubMed ID: 28481726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus vaccine virus shedding, viremia and clearance in infants with severe combined immune deficiency.
    Kaplon J; Cros G; Ambert-Balay K; Leruez-Ville M; Chomton M; Fremy C; Pothier P; Blanche S
    Pediatr Infect Dis J; 2015 Mar; 34(3):326-8. PubMed ID: 25742082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotavirus vaccine induced diarrhea in a child with severe combined immune deficiency.
    Werther RL; Crawford NW; Boniface K; Kirkwood CD; Smart JM
    J Allergy Clin Immunol; 2009 Sep; 124(3):600. PubMed ID: 19660805
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine.
    Hsieh YC; Wu FT; Hsiung CA; Wu HS; Chang KY; Huang YC
    Vaccine; 2014 Feb; 32(10):1199-204. PubMed ID: 24076325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus shedding in premature infants following first immunization.
    Smith CK; McNeal MM; Meyer NR; Haase S; Dekker CL
    Vaccine; 2011 Oct; 29(45):8141-6. PubMed ID: 21856359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
    Dennehy PH; Goveia MG; Dallas MJ; Heaton PM
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S36-42. PubMed ID: 18162245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged shedding of rotavirus in a geriatric inpatient.
    Mori I; Matsumoto K; Sugimoto K; Kimura M; Daimon N; Yokochi T; Kimura Y
    J Med Virol; 2002 Aug; 67(4):613-5. PubMed ID: 12116013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A short report on highlights of world-wide development of RIX4414: an European experience.
    Vesikari T; Karvonen A; Puustinen L; Szakal ED; Zeng SQ; Delem A; De Vos B
    Vaccine; 2006 May; 24(18):3779. PubMed ID: 16581159
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of shedding of the RIX4414 live attenuated rotavirus vaccine administered to adult volunteers.
    Zibrik L; Dove W; McArdle F; Rustom R; Hart CA; Jackson MJ
    Arch Virol; 2007; 152(10):1951-4. PubMed ID: 17623269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotavirus vaccines: recent developments and future considerations.
    Angel J; Franco MA; Greenberg HB
    Nat Rev Microbiol; 2007 Jul; 5(7):529-39. PubMed ID: 17571094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
    Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
    J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation.
    Clark HF; Burke CJ; Volkin DB; Offit P; Ward RL; Bresee JS; Dennehy P; Gooch WM; Malacaman E; Matson D; Walter E; Watson B; Krah DL; Dallas MJ; Schödel F; Kaplan kM; Heaton P
    Pediatr Infect Dis J; 2003 Oct; 22(10):914-20. PubMed ID: 14551493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotavirus vaccines: viral shedding and risk of transmission.
    Anderson EJ
    Lancet Infect Dis; 2008 Oct; 8(10):642-9. PubMed ID: 18922486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of an ideal rotavirus vaccine.
    Reisinger KS; Block SL
    Clin Pediatr (Phila); 2008 Jul; 47(6):555-63. PubMed ID: 18467670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
    Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
    J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.